OKO.A. Kuznetsova

O.A. Kuznetsova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


O.A. Kuznetsova has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Clinical diversity of mitochondrial pathology: five clinical case reports

    by S.A. Laptiyev, D.L. Strekalov, S.V. Rozenfeld, E.A. Efet, E.L. Efimova, A.YU. Baranov, M.L. Kosheleva, O.A. Kuznetsova, E.M. Djanklich, S.S. Volkova, et al.

    Mitochondrial diseases represent an essential share of genetic diseases. The variability of clinical manifestations of mitochondrial pathologies leads to significant difficulties in its diagnosis. Authors present five clinical case reports of pediatric patients with genetically confirmed mitochondrial diseases (Leber’s hereditary optic neuropathy, MERRF syndrome, mitochondrial complex I deficiency and mitochondrial encephalopathy due to mitochondrial and peroxisome fusion) that were all observed in the University Clinic of the Saint Petersburg State Pediatric Medical University (Saint Petersburg, Russia) in 2021-2023. All the five patients were suggested to receive a personalized energotropic therapy coupled with ketogenic dietary nutrition whilst some did not adhere to the recommended prescriptions for a number of reasons such as insufficient awareness, relatively high cost of treatments etc. therefore beneficial effect of the administered therapy was observed in only two out of three relevant patients.


  • CLINICAL CASE OF LAMBERT–EATON MYASTHENIC SYNDROME IN A PATIENT WITH SEVERE ULCERATIVE COLITIS

    by T.V. Gabrusskaya, E.A. Kornienko, M.O. Revnova, N.B. Ulanova, E.V. Shilova, E.A. Efet, O.A. Kuznetsova, E.Yu. Makarova, G.V. Kondratyev, A.A. Artemyeva

    Вам открыли доступ к файлу. Отправлено с помощью Облако Mail.ru.


  • CLINICAL CASE OF SCHIMMELPENNING–FEUERSTEIN–MIMS SYNDROME WITH RHABDOMYOSARCOMA

    by V.V. Alexandrova, N.A. Granenkova, E.A. Efet, O.A. Kuznetsova, G.V. Kondratiev, I.S. Novikova, M.O. Revnova, T.V. Yakovleva, E.YU. Makarova

    The authors represent the clinical case observation of the Schimmelpenning-Feuerstein-Mims syndrome, a congenital dermatological-neurological disease, which includes an organoid epidermal nevus with a wide range of multiple organ dysfunction (neurological, skeletal, cardiovascular, ophthalmological and urological), complicated by the development of rhabdomyosarcoma in a patient. The predominant neurological manifestations of the syndrome are as follows: epilepsy, intellectual and focal disorders. The authors pay specialists’ attention to the complexity of establishing diagnosis and the importance of an interdisciplinary approach in the diagnosis and management in such kind of patients.


  • Association of acquired and congenital thrombophilic factors in a child with ischemic stroke

    by Карина Альбертовна Папаян, А.а. Шулятьева, А.с. Морозова, Е.а. Квапинская, О.а. Кузнецова

    Введение. Тромбоз остается одной из ведущих причин летальности населения. В связи с этим остро стоит вопрос своевременной диагностики причин и анализа провоцирующих факторов возникновения тромботических событий, в особенности у детей с генетически детерминированной тромбофилией. Цель описания клинического случая: демонстрация роли мультифакторности генеза тромбоза в сочетании с патологическими состояниями, усиливающими гемостатическую активность крови в детском возрасте, для дальнейшего прогнозирования развития ребенка и определения методов профилактики рецидивов тромботических осложнений во взрослом возрасте. Результаты. Мальчик А., в возрасте 7 лет перенес острое нарушение мозгового кровообращения по ишемическому типу от 25.08.16, которому предшествовала ревакцинация корь-паротит-краснуха , острый гастроэнтерит с эксикозом II степени, токсикозом и длительным периодом иммобилизации в течение 2 нед. На момент тромботического события установлена гипергомоцистеинемия (10 мкмоль/л при референсных значениях возрастной нормы 3,05,0 мкмоль/л). При выполнении молекулярно-генетического исследования выявлено 5 гетерозиготных полиморфизмов минорного риска тромбоза (MTHFR, MTRR, PAI1, FGB, ITGA22). На момент последней госпитализации (февраль 2019 г.) обнаружено снижение эффективности работы системы естественных антикоагулянтов по результатам теста генерации тромбина, а также умеренное снижение активности антикоагулянта протеина С до 74 (при нижней границе нормы 75). Заключение. Мультифакторность тромбоза у детей предусматривает комплексный подход к диагностике и лечению, а также профилактике рецидивов тромботического события с обязательным контролем в динамике состояния системы гемостаза, уровня естественных антикоагулянтов и гомоцистеина. Introduction. Thrombosis remains one of the leading causes of mortality in the population. Thereby the timely diagnosis and analysis of the triggering factors of thrombotic events, especially in cases of genetically determined thrombophilia in children is acute question. Aim: to demonstrate the role of the multifactor genesis of thrombosis in combination with pathological conditions that enhanced blood hemostatic activity in childhood, for further prediction and prophylaxis of recurrence of thrombotic events in adulthood. Results. Patient A. had an ischemic stroke when he was 7 years old. It was preceded by rubeola-parotitis-rubella revaccination, acute gastroenteritis with degree II excision, toxicosis and a long period of immobilization for 2 weeks. Hyperhomocysteinemia was revealed (10 mol/L, reference values of the age norm are 3.05.0 mol/L) at the time of the thrombotic event. Molecular genetics study identified 5 heterozygous polymorphisms of a minor risk of thrombosis (MTHFR, MTRR, PAI1, FGB, ITGA22). At the date of last hospitalization (February 2019) decreased efficiency of anticoagulant system (according to the results of the thrombin generation assay) and moderate decreasing of protein C activity to 74 (with a lower normal limit of 75) were found. Conclusion. The multifactorial nature of thrombosis in children provides an integrated approach to the diagnosis, treatment and prophylaxis of recurrence of thrombotic events with monitoring of hemostasis, levels of natural anticoagulants and homocysteine.